Matteo Giovanni Della Porta

Active 1992–2025

125
Papers
19,592
Citations
66
h-index
110
i10-index

Citations

Citations per year for Matteo Giovanni Della Porta1989: 1 citations1996: 1 citations1999: 2 citations2002: 1 citations2003: 2 citations2004: 4 citations2005: 17 citations2006: 46 citations2007: 67 citations2008: 101 citations2009: 93 citations2010: 100 citations2011: 99 citations2012: 190 citations2013: 181 citations2014: 225 citations2015: 201 citations2016: 191 citations2017: 173 citations2018: 136 citations2019: 431 citations2020: 476 citations2021: 564 citations2022: 521 citations2023: 405 citations2024: 645 citations2025: 316 citations2026: 6 citations1990–1995: no citations, so these years are not shown1997–1998: no citations, so these years are not shown2000–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,507 citing papers, 22.7% of this breakdownItaly: 639 citing papers, 9.6% of this breakdownGermany: 577 citing papers, 8.7% of this breakdownUnited Kingdom: 512 citing papers, 7.7% of this breakdownFrance: 392 citing papers, 5.9% of this breakdownSpain: 303 citing papers, 4.6% of this breakdownChina: 281 citing papers, 4.2% of this breakdownNetherlands: 204 citing papers, 3.1% of this breakdownCanada: 177 citing papers, 2.7% of this breakdownJapan: 176 citing papers, 2.6% of this breakdownSweden: 175 citing papers, 2.6% of this breakdownSwitzerland: 150 citing papers, 2.2% of this breakdown
0%22.7%Other 23.4%

Fields

  • Medicine74.7%
  • Biochemistry, Genetics and Molecular Biology18.6%
  • Immunology and Microbiology4%
  • Computer Science1.2%
  • Neuroscience0.4%
  • Energy0.2%
  • Other0.9%

Topics

  • Acute Myeloid Leukemia Research16.5%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment8.4%
  • Cancer Genomics and Diagnostics2.8%
  • Hematopoietic Stem Cell Transplantation2.7%
  • RNA Research and Splicing2.7%
  • RNA modifications and cancer2.6%
  • Other64.3%

Coauthors

All papers

Open in search
  1. Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Akifumi Takaori‐Kondo, Takayuki Ishikawa, Shigeru Chiba, Senji Kasahara, Yasushi Miyazaki, Agnès Viale, Kety Huberman, Pierre Fenaux, Monika Beličková, Michael R. Savona, Virginia M. Klimek, Fábio Pires de Souza Santos, Jacqueline Boultwood, Ιoannis Kotsianidis, Valeria Santini, Françesc Solé, Uwe Platzbecker, Michael Heuser, Peter Valent, Kazuma Ohyashiki, Carlo Finelli, Maria Teresa Voso, Lee‐Yung Shih, Michaëla Fontenay, Joop H. Jansen, José Cervera, Norbert Gattermann, Benjamin L. Ebert, Rafael Bejar, Luca Malcovati, Mario Cazzola, Seishi Ogawa, Eva Hellström‐Lindberg, Elli Papaemmanuil - NEJM Evidence 2022 cited by 813

  2. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline Boultwood, Fábio Pires de Souza Santos, Julie Schanz, Senji Kasahara, Takayuki Ishikawa, Hisashi Tsurumi, Akifumi Takaori‐Kondo, Toru Kiguchi, Chantana Polprasert, John M. Bennett, Virginia M. Klimek, Michael R. Savona, Monika Beličková, Christina Ganster, Laura Palomo, Guillermo Sanz, Lionel Adès, Matteo Giovanni Della Porta, Harold K. Elias, Alexandra Smith, Yesenia Werner, Minal Patel, Agnès Viale, Katelynd Vanness, Donna Neuberg, Kristen E. Stevenson, Kamal Menghrajani, Kelly L. Bolton, Pierre Fenaux, Andrea Pellagatti, Uwe Platzbecker, Michael Heuser, Peter Valent, Shigeru Chiba, Yasushi Miyazaki, Carlo Finelli, Maria Teresa Voso, Lee‐Yung Shih, Michaëla Fontenay, Joop H. Jansen, José Cervera, Yoshiko Atsuta, Norbert Gattermann, Benjamin L. Ebert, Rafael Bejar, Peter L. Greenberg, Mario Cazzola, Eva Hellström-Lindberg, Seishi Ogawa, Elli Papaemmanuil - Nature Medicine 2020 cited by 636

  3. Clinical and biological implications of driver mutations in myelodysplastic syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony R. Green, Jacqueline Boultwood, Paresh Vyas, Eva Hellström‐Lindberg, David Bowen, Mario Cazzola, Michael R. Stratton, Peter J. Campbell - Blood 2013 cited by 1,832

  4. SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E. Joanna Baxter, J Score, Anna Gallì, Matteo Giovanni Della Porta, Erica Travaglino, Michael J. Groves, Sudhir Tauro, Nikhil C. Munshi, Kristina Anderson, Adel K. El‐Naggar, Andrej Fischer, Ville Mustonen, Alan J. Warren, Nicholas C.P. Cross, Anthony R. Green, P. Andrew Futreal, Michael R. Stratton, Peter J. Campbell - New England Journal of Medicine 2011 cited by 1,216

  5. Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2023 cited by 164

  6. Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JCO Clinical Cancer Informatics 2023 cited by 87

  7. A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2022 cited by 116

  8. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2013 cited by 667

  9. Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesco Passamonti, Fabio Ciceri, Niccolò Bolli, Alessandro Rambaldi, Wolfgang Kern, Shahram Kordasti, Françesc Solé, Laura Palomo, Guillermo Sanz, Armando Santoro, Uwe Platzbecker, Pierre Fenaux, Luciano Milanesi, Torsten Haferlach, Gastone Castellani, Matteo Giovanni Della Porta - Journal of Clinical Oncology 2021 cited by 225

  10. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2015 cited by 428

  11. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Niccolò Bolli, Alessandro Rambaldi, Francesco Passamonti, Victor Savevski, Armando Santoro, Ulrich Germing, Shahram Kordasti, Valeria Santini, María Díez‐Campelo, Guillermo Sanz, Françesc Solé, Wolfgang Kern, Uwe Platzbecker, Lionel Adès, Pierre Fenaux, Torsten Haferlach, Gastone Castellani, Matteo Giovanni Della Porta - Journal of Clinical Oncology 2023 cited by 111

  12. Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells

    Authors: , , , , , , , - Frontiers in Immunology 2019 cited by 85

  13. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrizia Tosi, Francesco Lanza, Massimo Massaia, Mauro Turrini, Felicetto Ferrara, Carmela Gurrieri, Daniele Vallisa, Maurizio Martelli, Enrico Derenzini, Attilio Guarini, Annarita Conconi, Annarosa Cuccaro, Laura Cudillo, Domenico Russo, Fabrizio Ciambelli, Anna Maria Scattolin, Mario Luppi, Carmine Selleri, Elettra Ortu La Barbera, Celestino Ferrandina, Nicola Di Renzo, Attilio Olivieri, Monica Bocchia, Massimo Gentile, Francesco Marchesi, Pellegrino Musto, Augusto B. Federici, Anna Candoni, Adriano Venditti, Carmen Fava, Antonio Pinto, Piero Galieni, Luigi Rigacci, Daniele Armiento, Fabrizio Pane, Margherita Oberti, Patrizia Zappasodi, Carlo Visco, Matteo Franchi, Paolo Grossi, Lorenza Bertù, Giovanni Corrao, Livio Pagano, Paolo Corradini - The Lancet Haematology 2020 cited by 554

  14. Molecular taxonomy of myelodysplastic syndromes and its clinical implications

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matteo Giovanni Della Porta, Pierre Fenaux, Monika Beličková, Michael R. Savona, Virginia M. Klimek, Fábio Pires de Souza Santos, Jacqueline Boultwood, Ιoannis Kotsianidis, Valeria Santini, Françesc Solé, Uwe Platzbecker, Michael Heuser, Peter Valent, Carlo Finelli, Maria Teresa Voso, Lee‐Yung Shih, Michaëla Fontenay, Joop H. Jansen, José Cervera, Norbert Gattermann, Benjamin L. Ebert, Rafael Bejar, Luca Malcovati, Seishi Ogawa, M. Cazzola, Eva Hellström‐Lindberg, Elli Papaemmanuil - Blood 2024 cited by 73

  15. Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making

    Authors: , , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 860

  16. Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance

    Authors: , , , , , , , , , , , , - Haematologica 2017 cited by 118

  17. MOSAIC: An Artificial Intelligence–Based Framework for Multimodal Analysis, Classification, and Personalized Prognostic Assessment in Rare Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gastone Castellani - JCO Clinical Cancer Informatics 2024 cited by 19

  18. Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesca Bonifazi, Riccardo Bellazzi, Elli Papaemmanuil, Armando Santoro, Emilio Paolo Alessandrino, Alessandro Rambaldi, Mario Cazzola - Journal of Clinical Oncology 2016 cited by 255

  19. The SPID-GBA study

    Authors: , , , , , , , , , , , , , - Neurology Genetics 2020 cited by 65

  20. Opportunities and Challenges of Synthetic Data Generation in Oncology

    Authors: , , , , , , , , , - JCO Clinical Cancer Informatics 2023 cited by 36

  21. Clinical relevance of clonal hematopoiesis in persons aged ≥80 years

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rocco Piazza, Giovanni Corrao, Claudia Sala, Alberto Termanini, Laura Giordano, Paolo Detoma, Aurelio Malabaila, Luca Sala, Stefano Rosso, Roberto Zanetti, Claudia Saitta, Elena Riva, Gianluigi Condorelli, Francesco Passamonti, Armando Santoro, Françesc Solé, Uwe Platzbecker, Pierre Fenaux, Niccolò Bolli, Gastone Castellani, Wolfgang Kern, George S. Vassiliou, Torsten Haferlach, Ugo Lucca, Matteo Giovanni Della Porta - Blood 2021 cited by 72

  22. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeroen te Marvelde, Denise A. Wells, Vincent H. J. van der Velden, Wolfgang Kern, Arjan A. van de Loosdrecht - Cytometry Part B Clinical Cytometry 2022 cited by 50

  23. Generative Adversarial Networks in Brain Imaging: A Narrative Review

    Authors: , , , , , - Journal of Imaging, J. Imaging 2022 cited by 49

  24. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 494